Orange Book product · Generic (ANDA)
PERAMPANEL
PERAMPANEL
Generic (ANDA)ANDA 218152TE ABRX MSN
At a glance
Jul 11, 2025
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 11, 2025
11 mo ago
Exclusivity ends · PC
Patent-challenge (180-day generic) exclusivity
Jun 14, 2026
5 d ago
Today
Pharmaceutical detail
Active ingredient
PERAMPANEL
Strength
0.5MG/ML
Dosage form
SUSPENSION
Route
ORAL
TE code
AB
Application
ANDA 218152
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PERAMPANEL
Marketing exclusivity (1)
- PCPatent-challenge (180-day generic) exclusivity
Jun 14, 2026
5 d ago
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
